Choroid Plexus Cell Atlas for Single-Cell Marker Discovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Limited understanding of the molecular mechanisms governing the functions of the choroid plexus, including its cellular composition, hinders therapeutic applications for neurologic diseases such as brain infection, autism, schizophrenia, and Alzheimer's disease.
Innovation Solution
Development of a cell atlas of choroid plexus cell types, including epithelial, endothelial, immune, and mesenchymal cells, with specific markers and therapeutic targets, using CRISPR-Cas systems for gene engineering and modulation of cell-cell interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional bulk tissue analysis methods are used, then sample preparation is simple, but cellular heterogeneity cannot be resolved and cell-type-specific markers cannot be identified
Solution Approach 1:
The patent applies segmentation by dividing the bulk choroid plexus tissue into individual single cells through isolation techniques. This allows each cell type (epithelial, endothelial, mesenchymal, immune cells) to be separately characterized using scRNA-seq, thereby resolving cellular heterogeneity and identifying cell-type-specific gene expression profiles that would be masked in bulk analysis.
Solution Approach 2:
The patent uses computational bioinformatics pipelines as an intermediary between raw sequencing data and biological interpretation. The multi-step computational workflow including quality control, alignment, quantification, and differential expression analysis enables precise cellular composition characterization while managing the complexity of single-cell data processing.
2Loss of information
If cell isolation techniques are developed to access choroid plexus cells, then cellular networks can be comprehensively characterized, but the technical complexity and difficulty of access increase
Solution Approach 1:
The patent performs preliminary action by establishing optimized cell isolation protocols and computational pipelines before conducting the main characterization study. The detailed methods section provides pre-tested procedures for dissociating choroid plexus tissue into single cells while preserving RNA integrity, enabling other researchers to replicate the approach without facing the same initial technical barriers.
3Reliability
If gene expression modulation techniques are applied to choroid plexus cells, then therapeutic benefits for neurodegenerative diseases can be achieved, but the complexity of gene manipulation increases
Solution Approach 1:
The patent employs CRISPR-Cas9 gene editing technology that enables self-service through programmable DNA targeting. The system uses guide RNAs to direct Cas9 nuclease to specific genomic locations, allowing precise modification of genes involved in oxidative stress and neural plasticity without requiring complex external manipulation systems. This programmable approach simplifies the delivery and implementation of gene modulation therapies.
Data Source
AI summary
A cell atlas of the Choroid Plexus is provided and includes novel markers for cell types. Novel cell types and methods of quantitating, detecting and isolating the cell types are disclosed. Methods of treatment, including for oxidative stress in the brain are provided, as well as methods for controlling differentiation, maintenance and/or function of the cell types disclosed herein.